Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.96 CAD | -1.66% | +8.03% | +169.09% |
04-22 | HC Wainwright Starts Cardiol Therapeutics With Buy Rating, $9 Price Target | MT |
04-01 | Cardiol Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+169.09% | 150M | |
+28.26% | 48.16B | |
-1.11% | 41.73B | |
+43.06% | 41.03B | |
-5.31% | 28.77B | |
+10.72% | 25.59B | |
-21.21% | 18.96B | |
+6.36% | 12.92B | |
+26.92% | 12.03B | |
-3.19% | 11.77B |
- Stock Market
- Equities
- CRDL Stock
- News Cardiol Therapeutics Inc.
- Cantor Fitzgerald Lowers Price Target to Cardiol Therapeutics to $5 From $6, Maintains Overweight Rating